title: Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist.
authors.affiliation: Department of Urology, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jeferguson@mdanderson.org.
authors.forename: James E
authors.initials: JE
authors.lastname: Ferguson
authors.affiliation: Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Surena F
authors.initials: SF
authors.lastname: Matin
mesh_terms: D051792:Basic Helix-Loop-Helix Proteins; D002292:Carcinoma, Renal Cell; D045744:Cell Line, Tumor; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D007680:Kidney Neoplasms; D051794:Von Hippel-Lindau Tumor Suppressor Protein
chemical_list: D051792:Basic Helix-Loop-Helix Proteins; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D051794:Von Hippel-Lindau Tumor Suppressor Protein